KI
LEGN icon

Kapitalo Investimentos’s Legend Biotech LEGN Stock Holding History

Kapitalo Investimentos’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,841
Closed -$334K – 624
2023
Q2 		$334K Buy
+4,841
New +$316K 0.06% 165

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Kapitalo Investimentos's LEGN Position: Q3 2023 in Review

Kapitalo Investimentos sold out of Legend Biotech (LEGN) in Q3 2023, closing a stake of 4,841 shares — an estimated $334K sold.

Kapitalo Investimentos first reported a position in LEGN in Q2 2023 and held it in 1 quarter. The position peaked at $334K in Q2 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2023.

  • Kapitalo Investimentos reported no remaining Legend Biotech position as of Q3 2023 after selling out during the quarter.
  • Kapitalo Investimentos sold 4,841 Legend Biotech shares in Q3 2023, an estimated $334K.
  • Kapitalo Investimentos first reported a position in Legend Biotech in Q2 2023 and held it in 1 quarter.
  • Kapitalo Investimentos's Legend Biotech position peaked at $334K in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2023.

Based on Kapitalo Investimentos's 13F filing for Q3 2023, filed 29 Mar 2024.